Roughly 50% of dogs over the age of 10 years will develop cancer. Animals are now part of the family, and veterinary medical care now approximates what is available in humans. We are now at a pivotal time where AI platforms and products can expedite clinical discovery and decision – making and accelerate innovation. In this talk, we will provide a high-level overview of comparative AI and the work our team has initiated to evaluate both radiomic and language-based models in veterinary medicine.

About the Speakers

Dr. Christopher Pinard, DVM DVSc DACVIM (Oncology) is the CEO and co-founder of ANI.ML Health Inc., an adjunct professor in the Department of Clinical Studies at the Ontario Veterinary College, University of Guelph, a Medical Oncologist at Lakeshore Animal Health Partners, a Research Fellow at Sunnybrook Research Institute, and a Faculty Affiliate with the Centre for Advancing Responsible and Ethical Artificial Intelligence (CARE-AI) at the University of Guelph. His research focuses on comparative computational oncology and the development of computer vision and language model-based tools for clinical applications.

Dr. Kuan-Chuen Wu builds A.I. products and Engineering solutions via scientific research, technological development, and global teaching. With a Harvard-Stanford education in multi-disciplinary engineering, data science, and business management, he leads multi-functional teams and communities in generative A.I. and predictive A.I. using hardware, software, theory plus ingenuity for societal good.

Learn more:

• ANI.ML - https://www.animl.health/

Recorded on Sept 19, 2024 at the Visual AI in Healthcare virtual event.